Antidepressant Medications May Benefit Only Persons With Severe Depression

On January 6, 2010, in Depression, Medication, by Christopher Fisher, PhD

BMED Report detailed the effectiveness of anti-depressant medication with only the most severely depressed in 2008 in “Anti-Depressant Medication & The Placebo Effect”. A new analysis of randomized trials indicates that compared with placebo, the magnitude of benefit of antidepressant medications varies with the severity of depressive symptoms, and may provide little benefit for patients [...]

Fluoxetine Does Not Reduce Repetitive Behaviors in Children with Autism

On February 21, 2009, in Autism, Medication, by Christopher Fisher, PhD
child_playing

Autism Speaks and the Autism Clinical Trials Network report that a new low dose, melt-in-your-mouth version of Fluoxetine failed to reduce repetitive behaviors in children and adolescents diagnosed with Autism. Physicians’ clinical observations that Fluoxetine controlled these behaviors spurred this research. Fluoxetine is selective serotonin reuptake inhibitor (SSRI) that is commonly referred to as a [...]

Anti-Depressant Medication & The Placebo Effect

On July 16, 2008, in Depression, Medication, by Christopher Fisher, PhD
medication_bottle

No better way to kick off a new research website than with controversial research.  Let’s start first with the concept of a “placebo effect.”  The placebo effect is very common in most forms of healthcare.  When people who are ill (mentally or physically) believe that they will get better – guess what – they do.  [...]